Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 5
2009 10
2010 7
2011 7
2012 8
2013 8
2014 14
2015 20
2016 13
2017 19
2018 27
2019 18
2020 23
2021 26
2022 15
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.
Deek MP, Van der Eecken K, Sutera P, Deek RA, Fonteyne V, Mendes AA, Decaestecker K, Kiess AP, Lumen N, Phillips R, De Bruycker A, Mishra M, Rana Z, Molitoris J, Lambert B, Delrue L, Wang H, Lowe K, Verbeke S, Van Dorpe J, Bultijnck R, Villeirs G, De Man K, Ameye F, Song DY, DeWeese T, Paller CJ, Feng FY, Wyatt A, Pienta KJ, Diehn M, Bentzen SM, Joniau S, Vanhaverbeke F, De Meerleer G, Antonarakis ES, Lotan TL, Berlin A, Siva S, Ost P, Tran PT. Deek MP, et al. Among authors: lumen n. J Clin Oncol. 2022 Oct 10;40(29):3377-3382. doi: 10.1200/JCO.22.00644. Epub 2022 Aug 24. J Clin Oncol. 2022. PMID: 36001857 Free PMC article.
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.
Ost P, Reynders D, Decaestecker K, Fonteyne V, Lumen N, De Bruycker A, Lambert B, Delrue L, Bultijnck R, Claeys T, Goetghebeur E, Villeirs G, De Man K, Ameye F, Billiet I, Joniau S, Vanhaverbeke F, De Meerleer G. Ost P, et al. Among authors: lumen n. J Clin Oncol. 2018 Feb 10;36(5):446-453. doi: 10.1200/JCO.2017.75.4853. Epub 2017 Dec 14. J Clin Oncol. 2018. PMID: 29240541 Clinical Trial.
Benchmarking blood collection tubes and processing intervals for extracellular vesicle performance metrics.
Dhondt B, Pinheiro C, Geeurickx E, Tulkens J, Vergauwen G, Van Der Pol E, Nieuwland R, Decock A, Miinalainen I, Rappu P, Schroth G, Kuersten S, Vandesompele J, Mestdagh P, Lumen N, De Wever O, Hendrix A. Dhondt B, et al. Among authors: lumen n. J Extracell Vesicles. 2023 May;12(5):e12315. doi: 10.1002/jev2.12315. J Extracell Vesicles. 2023. PMID: 37202906 Free PMC article.
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer.
Sutera PA, Shetty AC, Hakansson A, Van der Eecken K, Song Y, Liu Y, Chang J, Fonteyne V, Mendes AA, Lumen N, Delrue L, Verbeke S, De Man K, Rana Z, Hodges T, Hamid A, Roberts N, Song DY, Pienta K, Ross AE, Feng F, Joniau S, Spratt D, Gillessen S, Attard G, James ND, Lotan T, Davicioni E, Sweeney C, Tran PT, Deek MP, Ost P. Sutera PA, et al. Among authors: lumen n. Ann Oncol. 2023 Jul;34(7):605-614. doi: 10.1016/j.annonc.2023.04.515. Epub 2023 May 8. Ann Oncol. 2023. PMID: 37164128 Free article.
Advances in Urogenital Trauma and Reconstruction.
Lumen N, Martins F, Palminteri E, Ploumidis A. Lumen N, et al. Biomed Res Int. 2020 Feb 19;2020:2907204. doi: 10.1155/2020/2907204. eCollection 2020. Biomed Res Int. 2020. PMID: 32149097 Free PMC article. No abstract available.
AUTHOR REPLY.
Verla W, Oosterlinck W, Waterloos M, Spinoit AF, Lumen N. Verla W, et al. Among authors: lumen n. Urology. 2020 Apr;138:165. doi: 10.1016/j.urology.2019.11.068. Urology. 2020. PMID: 32252948 No abstract available.
Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer.
Sutera P, Song Y, Van der Eecken K, Shetty AC, English K, Hodges T, Chang J, Fonteyne V, Rana Z, Ren L, Mendes AA, Lumen N, Delrue L, Verbeke S, De Man K, Song DY, Pienta K, Feng FY, Joniau S, Lotan T, Lane B, Kiess A, Rowe S, Pomper M, DeWeese T, Deek M, Sweeney C, Ost P, Tran PT. Sutera P, et al. Among authors: lumen n. Eur Urol. 2023 Dec;84(6):531-535. doi: 10.1016/j.eururo.2023.04.025. Epub 2023 May 10. Eur Urol. 2023. PMID: 37173210 Free article.
Author Reply.
Poelaert F, Lumen N. Poelaert F, et al. Among authors: lumen n. Urology. 2017 Aug;106:152. doi: 10.1016/j.urology.2017.02.055. Epub 2017 May 24. Urology. 2017. PMID: 28550941 No abstract available.
Radiotherapy for renal-cell carcinoma.
De Meerleer G, Khoo V, Escudier B, Joniau S, Bossi A, Ost P, Briganti A, Fonteyne V, Van Vulpen M, Lumen N, Spahn M, Mareel M. De Meerleer G, et al. Among authors: lumen n. Lancet Oncol. 2014 Apr;15(4):e170-7. doi: 10.1016/S1470-2045(13)70569-2. Lancet Oncol. 2014. PMID: 24694640 Review.
190 results